Related references
Note: Only part of the references are listed.Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
David P. Nichols et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Critically Ill Patient with Multidrug-Resistant Acinetobacter baumannii Respiratory Infection Successfully Treated with Intravenous and Nebulized Bacteriophage Therapy
Sohail Rao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Considerations for the Use of Phage Therapy in Clinical Practice
Gina A. Suh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice
Rachel Yoon Kyung Chang et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats
Josef Prazak et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Parallel evolution of Pseudomonas aeruginosa phage resistance and virulence loss in response to phage treatment in vivo and in vitro
Meaghan Castledine et al.
ELIFE (2022)
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection
Jerry A. Nick et al.
CELL (2022)
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review
Saartje Uyttebroek et al.
LANCET INFECTIOUS DISEASES (2022)
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection
Jessica S. Little et al.
NATURE COMMUNICATIONS (2022)
Mitigation of evolved bacterial resistance to phage therapy
Clara Torres-Barcelo et al.
CURRENT OPINION IN VIROLOGY (2022)
Recent progress toward the implementation of phage therapy in Western medicine
Jean-Paul Pirnay et al.
FEMS MICROBIOLOGY REVIEWS (2022)
Pharmacokinetics and Time-Kill Study of Inhaled Antipseudomonal Bacteriophage Therapy in Mice
Michael Y. T. Chow et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Phages and their potential to modulate the microbiome and immunity
Sara Federici et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial
Lorenz Leitner et al.
LANCET INFECTIOUS DISEASES (2021)
Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model
Yu Lin et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
Phage cocktail powder for Pseudomonas aeruginosa respiratory infections
Mengyu Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Bacteriophage as a Novel Therapeutic Weapon for Killing Colistin-Resistant Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Bacteria
Seyed Mohammad Mousavi et al.
CURRENT MICROBIOLOGY (2021)
A phage-encoded anti-activator inhibits quorum sensing in Pseudomonas aeruginosa
Megha Shah et al.
MOLECULAR CELL (2021)
Bacteriophage therapy for infections in CF
Benjamin K. Chan et al.
PEDIATRIC PULMONOLOGY (2021)
A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient
David Lebeaux et al.
VIRUSES-BASEL (2021)
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease
Xin Tan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Potential of Therapeutic Bacteriophages in Nosocomial Infection Management
Nannan Wu et al.
FRONTIERS IN MICROBIOLOGY (2021)
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients
Nannan Wu et al.
EMERGING MICROBES & INFECTIONS (2021)
Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections
Xiang Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Survival Comes at a Cost: A Coevolution of Phage and Its Host Leads to Phage Resistance and Antibiotic Sensitivity of Pseudomonas aeruginosa Multidrug Resistant Strains
Sarshad Koderi Valappil et al.
FRONTIERS IN MICROBIOLOGY (2021)
Expression of virulence factors by Pseudomonas aeruginosa biofilm after bacteriophage infection
Viviane de Cassia Oliveira et al.
MICROBIAL PATHOGENESIS (2021)
The Prophage and Plasmid Mobilome as a Likely Driver of Mycobacterium abscessus Diversity
Rebekah M. Dedrick et al.
MBIO (2021)
A prevalent and culturable microbiota links ecological balance to clinical stability of the human lung after transplantation
Sudip Das et al.
NATURE COMMUNICATIONS (2021)
Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection
Andre Mu et al.
MICROBIOME (2021)
Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA
Luca G. Valente et al.
BMC RESEARCH NOTES (2021)
Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection
Rebekah M. Dedrick et al.
NATURE MEDICINE (2021)
Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance
Joshua M. Borin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Successful Treatment of Staphylococcus aureus Prosthetic Joint Infection with Bacteriophage Therapy
Claudia Ramirez-Sanchez et al.
VIRUSES-BASEL (2021)
The Safety and Toxicity of Phage Therapy: A Review of Animal and Clinical Studies
Dan Liu et al.
VIRUSES-BASEL (2021)
Immune Response to Therapeutic Staphylococcal Bacteriophages in Mammals: Kinetics of Induction, Immunogenic Structural Proteins, Natural and Induced Antibodies
Zuzanna Kazmierczak et al.
FRONTIERS IN IMMUNOLOGY (2021)
Low Immunogenicity of Intravesical Phage Therapy for Urogenitary Tract Infections
Slawomir Letkiewicz et al.
ANTIBIOTICS-BASEL (2021)
Phage Therapy: The Pharmacology of Antibacterial Viruses
Katarzyna Danis-Wlodarczyk et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
Bacteriophage Encapsulation Using Spray Drying for Phage Therapy
Danish J. Malik
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
Eradication of a Multidrug-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Isolate Following Oral and Intra-rectal Therapy With a Custom Made, Lytic Bacteriophage Preparation
Mario Corbellino et al.
CLINICAL INFECTIOUS DISEASES (2020)
A Dutch Case Report of Successful Treatment of Chronic Relapsing Urinary Tract Infection with Bacteriophages in a Renal Transplant Patient
Saskia Kuipers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Outcomes of Adult Patients With Septic Shock Undergoing Extracorporeal Membrane Oxygenation Therapy
Laura C. Myers et al.
ANNALS OF THORACIC SURGERY (2020)
Safety of bacteriophage therapy in severe Staphylococcus aureus infection
Aleksandra Petrovic Fabijan et al.
NATURE MICROBIOLOGY (2020)
Quantitative Models of Phage-Antibiotic Combination Therapy
Rogelio A. Rodriguez-Gonzalez et al.
MSYSTEMS (2020)
Overexpression of AmpC Promotes Bacteriophage Lysis of Ampicillin-Resistant Escherichia coli
Shuang Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections
Majid Taati Moghadam et al.
INFECTION AND DRUG RESISTANCE (2020)
Phage T7 DNA mimic protein Ocr is a potent inhibitor of BREX defence
Artem Isaev et al.
NUCLEIC ACIDS RESEARCH (2020)
Bacteriophage Therapy for Critical Infections Related to Cardiothoracic Surgery
Evgenii Rubalskii et al.
ANTIBIOTICS-BASEL (2020)
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan-drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient
Andrew B. Gainey et al.
PEDIATRIC PULMONOLOGY (2020)
Trading-off and trading-up in the world of bacteria–phage evolution
Alita R. Burmeister et al.
CURRENT BIOLOGY (2020)
Combined Bacteriophage and Antibiotic Treatment PreventsPseudomonas aeruginosaInfection of Wild Type andcftr- Epithelial Cells
Alexandre Luscher et al.
FRONTIERS IN MICROBIOLOGY (2020)
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States
Saima Aslam et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase
Agnieszka Latka et al.
SCIENTIFIC REPORTS (2020)
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae
Juan Bao et al.
EMERGING MICROBES & INFECTIONS (2020)
Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
Thaysa Leite Tagliaferri et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination
Karoline Henriksen et al.
PATHOGENS AND DISEASE (2019)
Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients
Rachel Yoon Kyung Chang et al.
AAPS JOURNAL (2019)
Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient
Nancy Law et al.
INFECTION (2019)
Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
Rebekah M. Dedrick et al.
NATURE MEDICINE (2019)
Fast phage detection and quantification: An optical density-based approach
Denis Rajnovic et al.
PLOS ONE (2019)
Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia
Josef Prazak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
Saima Aslam et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Dynamic Modulation of the Gut Microbiota and Metabolome by Bacteriophages in a Mouse Model
Bryan B. Hsu et al.
CELL HOST & MICROBE (2019)
Bacteriophage Therapy of Ventilator-associated Pneumonia and Empyema Caused by Pseudomonas aeruginosa
Susan Maddocks et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Harry G. M. Heijerman et al.
LANCET (2019)
Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies
Krystyna Dabrowska et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2019)
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
P. G. Middleton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Phage resistance at the cost of virulence: Listeria monocytogenes serovar 4b requires galactosylated teichoic acids for InlB-mediated invasion
Eric T. Sumrall et al.
PLOS PATHOGENS (2019)
Induction of Phage-Specific Antibodies by Two Therapeutic Staphylococcal Bacteriophages Administered per os
Joanna Majewska et al.
FRONTIERS IN IMMUNOLOGY (2019)
Jet nebulization of bacteriophages with different tail morphologies - Structural effects
Sharon Shui Yee Leung et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
Patrick Jault et al.
LANCET INFECTIOUS DISEASES (2019)
Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System
Jonas D. Van Belleghem et al.
VIRUSES-BASEL (2019)
DISARM is a widespread bacterial defence system with broad anti-phage activities
Gal Ofir et al.
NATURE MICROBIOLOGY (2018)
Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa
Jumpei Uchiyama et al.
ARCHIVES OF VIROLOGY (2018)
History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology
Yoshizumi Ishino et al.
JOURNAL OF BACTERIOLOGY (2018)
Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report
N. Hoyle et al.
RESEARCH IN MICROBIOLOGY (2018)
Phage Therapy Faces Evolutionary Challenges
Clara Torres-Barcelo
VIRUSES-BASEL (2018)
Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains
Christine Rohde et al.
VIRUSES-BASEL (2018)
Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms
Dilini Kumaran et al.
FRONTIERS IN MICROBIOLOGY (2018)
Phage Therapy for a MultidrugResistant Acinetobacter baumannii Craniectomy Site Infection
Stephanie LaVergne et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
Phage-Antibiotic Synergy via Delayed Lysis
Minjin Kim et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)
Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus
Tamta Tkhilaishvili et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa
Yu Lin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Phage treatment of an aortic graft infected with & IT;Pseudomonas aeruginosa & IT;
Benjamin K. Chan et al.
EVOLUTION MEDICINE AND PUBLIC HEALTH (2018)
Proof-of-Principle Study in a Murine Lung Infection Model of Antipseudomonal Activity of Phage PEV20 in a Dry-Powder Formulation
Rachel Yoon Kyung Chang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence
Frank Oechslin et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Lysogeny in nature: mechanisms, impact and ecology of temperate phages
Cristina Howard-Varona et al.
ISME JOURNAL (2017)
Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler
Nicholas B. Carrigy et al.
PHARMACEUTICAL RESEARCH (2017)
Bacterial Topography of the Healthy Human Lower Respiratory Tract
Robert P. Dickson et al.
MBIO (2017)
Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms
Waqes Nasir Chaudhry et al.
PLOS ONE (2017)
Pro- and anti-inflammatory responses of peripheral blood mononuclear cells induced by Staphylococcus aureus and Pseudomonas aeruginosa phages
Jonas D. Van Belleghem et al.
SCIENTIFIC REPORTS (2017)
Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection
Robert T. Schooley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen
Dwayne R. Roach et al.
CELL HOST & MICROBE (2017)
The Microbiome and the Respiratory Tract
Robert P. Dickson et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Personalized Therapeutic Cocktail of Wild Environmental Phages Rescues Mice from Acinetobacter baumannii Wound Infections
James M. Regeimbal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Microbiome in Cystic Fibrosis
Yvonne J. Huang et al.
CLINICS IN CHEST MEDICINE (2016)
Inhalation Study of Mycobacteriophage D29 Aerosol for Mice by Endotracheal Route and Nose-Only Exposure
Ke-yang Liu et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2016)
Biofilms: an emergent form of bacterial life
Hans-Curt Flemming et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Phages Fight Back: Inactivation of the CRISPR-Cas Bacterial Immune System by Anti-CRISPR Proteins
Karen L. Maxwell
PLOS PATHOGENS (2016)
Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy
Maciej Zaczek et al.
FRONTIERS IN MICROBIOLOGY (2016)
Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh
Shafiqul Alam Sarker et al.
EBIOMEDICINE (2016)
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Benjamin K. Chan et al.
SCIENTIFIC REPORTS (2016)
Burkholderia cepacia Complex Phage-Antibiotic Synergy (PAS): Antibiotics Stimulate Lytic Phage Activity
Fatima Kamal et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)
BREX is a novel phage resistance system widespread in microbial genomes
Tamara Goldfarb et al.
EMBO JOURNAL (2015)
Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface
Krystyna Dabrowska et al.
JOURNAL OF VIROLOGY (2014)
Phage Neutralization by Sera of Patients Receiving Phage Therapy
Marzanna Lusiak-Szelachowska et al.
VIRAL IMMUNOLOGY (2014)
Bacteriophage Therapy in Implant-Related Infections An Experimental Study
Cengiz Yilmaz et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2013)
Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models
Birendra R. Tiwari et al.
JOURNAL OF MICROBIOLOGY (2011)
Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa
T. Glonti et al.
JOURNAL OF APPLIED MICROBIOLOGY (2010)
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
A. Wright et al.
CLINICAL OTOLARYNGOLOGY (2009)
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Andre M. Comeau et al.
PLOS ONE (2007)
Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis
LA Kalish et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Population and evolutionary dynamics of phage therapy
BR Levin et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Share Paper
